$FOLD News La-Z-Boy shares rally after earnings beat

New Post Public Reply Private Reply Replies (0) Message Board

Dec 3, 2014 at 12:41 PM

$FOLD News

La-Z-Boy shares rally after earnings beat targets 4:41 p.m. Nov. 18, 2014 - Sue Chang
Urban Outfitters slides after earnings miss expectations 4:43 p.m. Nov. 17, 2014 - Sue Chang
Apple sets intraday record; PetSmart considers sale 12:56 p.m. Aug. 20, 2014 - Ben Eisen
Amicus Therapeutics shares up 25.6% in premarket trade 7:05 a.m. Aug. 20, 2014 - Ciara Linnane
Amicus Therapeutic’s Fabry treatment meets goals in late-stage trial 7:04 a.m. Aug. 20, 2014 - Michael Calia
U.S. stocks rise as risk appetite returns 4:19 p.m. April 29, 2014 - Anora Mahmudova
Twitter rallies ahead of earnings; 3D Systems retreats 2:49 p.m. April 29, 2014 - Sue Chang
U.S. stock futures climb; House prices flat in February 8:19 a.m. April 29, 2014 - Barbara Kollmeyer
Amicus rallies 52% premarket after positive trial results 6:25 a.m. April 29, 2014 - Sara Sjolin
Amicus rallies 52% premarket after positive trial results 6:08 a.m. April 29, 2014 - Sara Sjolin
Amicus stock down after it delays seeking Fabry OK 9:44 a.m. June 17, 2013 - MarketWatch.com
Friday’s biggest gaining and declining stocks 9:45 a.m. Jan. 4, 2013 - Greg Morcroft
Amicus Therapeutics up 11% in premarket 7:52 a.m. Jan. 4, 2013 - Steve Gelsi
Thursday’s movers: Apple ends in red on price cut 5:03 p.m. Dec. 20, 2012 - Sue Chang
Amicus down 45% in premarket 8:44 a.m. Dec. 20, 2012 - Steve Gelsi
Amicus falls 47% in premarket trades 7:52 a.m. Dec. 20, 2012 - Steve Gelsi
Bed Bath shares hurt, Jabil climbs after hours 6:31 p.m. Dec. 19, 2012 - Carla Mozee
Amicus, GlaxoSmithKline say treatment misses goal 5:22 p.m. Dec. 19, 2012 - MarketWatch.com
Amicus Therapeutics shares tumble 49% after hours 4:45 p.m. Dec. 19, 2012 - Carla Mozee
U.S. Hot stocks to watch 6:28 a.m. July 18, 2012 - MarketWatch.com

Will Amicus Therapeutics (FOLD) Continue to Surge Higher? - Tale of the Tape 9:41 a.m. Dec. 2, 2014 - Zacks.com
Amicus Therapeutics (FOLD) Weak On High Volume 10:00 a.m. Dec. 1, 2014 - TheStreet.com
InsiderInsights.com Daily Round Up 11/25/14: AAPL, FCF, AVID, SC 1:20 a.m. Nov. 26, 2014 - Seeking Alpha
Warren Buffett Pick CBI Tumbles On Rating Downgrade 1:00 p.m. Nov. 24, 2014 - TheStreet.com
BioMarin Buying Prosensa, Backing Up Troubled Drug 9:22 a.m. Nov. 24, 2014 - Investors Business Daily
InsiderInsights.com Daily Round Up 11/19/14: CJES, MGPI, PSX, STAA 2:58 a.m. Nov. 20, 2014 - Seeking Alpha
Amicus prices stock offering 7:13 a.m. Nov. 19, 2014 - Seeking Alpha
Amicus' Migalastat Should Have Smooth Sailing To FDA And European Approval For Fabry Disease 9:47 a.m. Nov. 18, 2014 - Seeking Alpha
Amicus Therapeutics, Inc. (FOLD) in Focus: Stock Soars 17.8% - Tale of the Tape 9:21 a.m. Nov. 18, 2014 - Zacks.com
Market News: Amicus Therapeutics, Urban Outfitters, Ford 5:08 p.m. Nov. 17, 2014 - TheStreet.com
Amicus Therapeutics (FOLD) Stock Surges Following Fabry Treatment Pill Results 11:27 a.m. Nov. 17, 2014 - TheStreet.com
Amicus Therapeutics (FOLD) Strong On High Relative Volume Today 10:02 a.m. Nov. 17, 2014 - TheStreet.com
Amicus Therapeutics' Fabry disease drug candidate improves cardiac health marker 7:31 a.m. Nov. 17, 2014 - Seeking Alpha
Amicus Drug Improves Marker of Heart Health in Fabry Patients 10:01 a.m. Nov. 15, 2014 - TheStreet.com
Amicus Therapeutics' (FOLD) CEO John Crowley on Q3 2014 Results - Earnings Call Transcript 9:50 a.m. Nov. 9, 2014 - Seeking Alpha
10-Q: AMICUS THERAPEUTICS INC 5:18 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
InsiderInsights.com Daily Round Up 10/28/14: POL, NHF, SLB, ATI 6:58 a.m. Oct. 29, 2014 - Seeking Alpha
Amicus Reports Additional Positive Data on Fabry Therapy - Analyst Blog 6:35 p.m. Oct. 20, 2014 - Zacks.com
Genervon ALS drug shows encouraging results 8:27 a.m. Oct. 20, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 10/6/14: IVAC, OPK, AVNW, CNBKA 10:45 a.m. Oct. 7, 2014 - Seeking Alpha

Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Over-Allotment Option 4:00 p.m. Nov. 24, 2014 - GlobeNewswire
Amicus Therapeutics Prices Underwritten Offering of Common Stock 7:16 p.m. Nov. 18, 2014 - GlobeNewswire
Amicus Therapeutics Announces Public Offering of Common Stock 4:01 p.m. Nov. 17, 2014 - GlobeNewswire
Amicus Therapeutics Announces Positive Phase 3 Data on Cardiac and Composite Endpoints from Fabry Monotherapy Study 012 at American Society of Nephrology 10:01 a.m. Nov. 15, 2014 - GlobeNewswire
Amicus Therapeutics Announces Third Quarter 2014 Financial Results and Corporate Updates 4:01 p.m. Nov. 6, 2014 - GlobeNewswire
Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 7:45 a.m. Oct. 22, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Additional Positive Phase 3 Data From Fabry Monotherapy Study 011 6:00 p.m. Oct. 19, 2014 - GlobeNewswire
Amicus Therapeutics to Present at Leerink Partners Rare Disease Roundtable 8:30 a.m. Sept. 30, 2014 - GlobeNewswire
Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 7:40 a.m. Sept. 12, 2014 - PR Newswire - PRF
Clinical Trial Results, Change of Corporate Name, New Products, and Completion of Acquisition - Research Reports on GSK, Amicus, WellPoint, IDEXX and Endo 7:40 a.m. Aug. 25, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Positive Phase 3 Data From Fabry Monotherapy Study 012 5:00 a.m. Aug. 20, 2014 - GlobeNewswire
Pre-Market Review on Biotech Equities -- Exelixis, Novavax, Achillion Pharma, XOMA, and Amicus Therapeutics 7:50 a.m. Aug. 13, 2014 - PR Newswire - PRF
Amicus Therapeutics Announces Second Quarter 2014 Financial Results and Corporate Updates 3:01 p.m. Aug. 7, 2014 - GlobeNewswire
Amicus Therapeutics to Announce Second Quarter 2014 Financial Results on August 7, 2014 3:01 p.m. July 31, 2014 - GlobeNewswire
Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis 7:50 a.m. July 30, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry -- Research on Halozyme Therapeutics, XOMA, Amicus Therapeutics, and Arena Pharma 6:20 a.m. July 10, 2014 - PR Newswire - PRF
Amicus Therapeutics Analyst Report; Solid Pipeline and Near-term Catalysts by BrokerBank Securities, Inc. 1:55 p.m. July 7, 2014 - PR Newswire - PRF
Study Updates, Market Activity, Preclinical Data, and Oral Presentations - Analyst Notes on Amicus, Conatus, Dicerna, Epizyme and Array 5:30 a.m. July 3, 2014 - PR Newswire - PRF
Amicus Therapeutics Provides Updates and Final Analysis Plan for Phase 3 Fabry Monotherapy Study 012 6:00 a.m. June 30, 2014 - GlobeNewswire
Technical Coverage on Top Gainers -- Research on Fresh Market, First Bancorp, Amicus Therapeutics, and Magellan Petroleum 7:20 a.m. June 4, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rodeo Dental Gears Up for National Growth Surge

Rodeo Dental's Leadership Shuffle When you're talking about upping the ante in the dental world, you can't ignore the recent shake-up at Rodeo Dental & Orthodontics. They've decided to retool their corner office lineup, and this is where the folks in suits meet the folks with the steady hands in teeth. Co-Founder Dr. Saam Zarrabi is stepping into an Executive Chairman...

Graphic Packaging Names Berardinelli as HR Executive

A New Chapter in HR Leadership at Graphic Packaging September 8 marks a turning point for Graphic Packaging Holding Company with the appointment of Tatiana Berardinelli as their new Chief Human Resources Officer. As NYSE:GPK positions itself for ambitious growth, Berardinelli stands out for her knack for managing transformations and building cultures that thrive in...

CAPR Faces Lawsuit and FDA Delay: Investor Alert

Trouble Brewin' for Capricor Investors Buckle up, folks. Capricor Therapeutics (NASDAQ: CAPR) is caught in a storm, facing not just the lengthy arm of law with a securities class action, but also a seemingly endless wait with the FDA's decision on their lead product. We're talking serious implications for anyone with skin in the game. The FDA's Delayed Blessing So the...

Doug Larson Takes Helm at Integra Pool Covers

A Seasoned Pro Joins Integra Pool Covers Change is afoot over at Explore Industries. They just tapped Doug Larson to be the General Manager for their Integra Pool Covers division. Now, I've seen plenty of hiring announcements in my day, but this has got an interesting ring to it. With Doug on this ship, it's like bringing a wolf back to the wild. Larson's no stranger to...

Yardi Virtuoso AI to Shine at CAIC 2026 Toronto

The Scene in Toronto: Yardi's Big AI Showcase There's no denying it—Artificial Intelligence has muscled its way into practically every corner of the business world, and now it's making waves in real estate. Yardi, a familiar name in real estate tech circles, is gearing up to flaunt its Yardi Virtuoso Enterprise at the Canadian Apartment Investment Conference (CAIC) in...

USF Law Innovators: Leading AI Integration in Academics

Revolutionizing Legal Academia with AI If there's one thing that's caught my eye in the realm of education, it's how some folks over at the University of San Francisco School of Law are shaking things up. These legal eagles aren't messing around with the usual, archaic ways of teaching the law. Nope, they've dove headfirst into the future by hooking their curriculum to...

McCann Systems Scores Big with Dual AV Awards Wins

Piling Up the Accolades: McCann Systems Does It Again You know, getting industry awards can sometimes feel like counting beans, but when a company's snagging them year after year, that’s worth noting. McCann Systems is strutting its stuff with two Commercial Integrator Awards in 2026, cementing their reputation not just here in New Jersey, but across the AV industry....

Safety and Wellbeing as Key Business Strategy Focus

Revolutionizing Safety in the Workplace Cracking the typical mindset of treating employee safety as a checkbox item, Debra Wein, CEO and Founder of Wellness Workdays, is set to shake up the NSC Safety Congress & Expo. Her upcoming session, titled "Transforming Safety and Wellbeing into a Competitive Business Advantage," isn't just a run-of-the-mill talk. It's a call to...

Alcatraz AI: A Silent Titan in Data Center Security

Why Alcatraz AI is the Security of Choice Forget flashy press releases and splashy marketing campaigns. Alcatraz AI, a company operating out of the hustle and bustle of Cupertino, has managed to quietly dominate a key sector without many folks being the wiser. What's their claim to fame, you ask? They're the chosen gatekeepers for over half of the hyperscale data centers...

APX Bridges Crypto & Traditional Finance With New Credit Line

The Future of Financial Bridging Now here's a scenario that might perk your ears up if you've ever toyed with digital assets: APX Lending is stepping up its game, bringing a regulated five-year revolving line of credit backed by Bitcoin and Ethereum to the world stage. It's like blending your grandma's tried-and-true savings approach with the whiz-bang allure of crypto. A...